Susan R. Pilat

585 total citations
15 papers, 424 citations indexed

About

Susan R. Pilat is a scholar working on Oncology, Hematology and Genetics. According to data from OpenAlex, Susan R. Pilat has authored 15 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Hematology and 3 papers in Genetics. Recurrent topics in Susan R. Pilat's work include Acute Myeloid Leukemia Research (5 papers), Colorectal Cancer Treatments and Studies (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Susan R. Pilat is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Colorectal Cancer Treatments and Studies (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Susan R. Pilat collaborates with scholars based in United States and Japan. Susan R. Pilat's co-authors include Razelle Kurzrock, Madeleine Duvic, Moshe Talpaz, Jörge E. Cortes, Carlos E. Bueso‐Ramos, Deborah A. Thomas, Avishay Sella, Alberto G. Ayala, Francisco H. Dexeus and Jae Y. Ro and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Susan R. Pilat

15 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Susan R. Pilat United States	10	166	128	111	87	73	15	424
Ken Gatter United States	16	130 0.8×	158 1.2×	132 1.2×	98 1.1×	94 1.3×	31	498
Peter Forsyth United Kingdom	7	130 0.8×	103 0.8×	136 1.2×	32 0.4×	152 2.1×	14	391
Tariq Muzzafar United States	14	149 0.9×	152 1.2×	176 1.6×	33 0.4×	220 3.0×	34	507
Hiromi Koiso Japan	12	152 0.9×	73 0.6×	110 1.0×	44 0.5×	143 2.0×	44	426
Andres Quesada United States	15	234 1.4×	135 1.1×	206 1.9×	130 1.5×	230 3.2×	59	639
Mariko Yabe United States	14	128 0.8×	142 1.1×	138 1.2×	25 0.3×	199 2.7×	39	466
D Scarpati Italy	12	155 0.9×	123 1.0×	63 0.6×	126 1.4×	28 0.4×	38	383
Henry Rappaport United States	6	130 0.8×	76 0.6×	78 0.7×	49 0.6×	153 2.1×	8	354
A. M. Gianni Italy	15	160 1.0×	294 2.3×	83 0.7×	78 0.9×	201 2.8×	26	619
Michele Cimminiello Italy	9	266 1.6×	88 0.7×	74 0.7×	26 0.3×	57 0.8×	19	359

Countries citing papers authored by Susan R. Pilat

Since Specialization

Citations

This map shows the geographic impact of Susan R. Pilat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan R. Pilat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan R. Pilat more than expected).

Fields of papers citing papers by Susan R. Pilat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan R. Pilat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan R. Pilat. The network helps show where Susan R. Pilat may publish in the future.

Co-authorship network of co-authors of Susan R. Pilat

This figure shows the co-authorship network connecting the top 25 collaborators of Susan R. Pilat. A scholar is included among the top collaborators of Susan R. Pilat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan R. Pilat. Susan R. Pilat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Patel, Maulik, Sadakatsu Ikeda, Susan R. Pilat, & Razelle Kurzrock. (2017). JAK1 Genomic Alteration Associated With Exceptional Response to Siltuximab in Cutaneous Castleman Disease. JAMA Dermatology. 153(5). 449–449. 8 indexed citations

Kurzrock, Razelle, Susan R. Pilat, Jill Hood, et al.. (2009). Project Zero Delay: A Process for Accelerating the Activation of Cancer Clinical Trials. Journal of Clinical Oncology. 27(26). 4433–4440. 13 indexed citations

Kurzrock, Razelle, Hagop M. Kantarjian, Srđan Verstovšek, et al.. (2008). Phase I Study of Alternate-Week Administration of Tipifarnib in Patients with Myelodysplastic Syndrome. Clinical Cancer Research. 14(2). 509–514. 15 indexed citations

Tsimberidou, Apostolia M., et al.. (2008). Survival of patients in a phase I clinic: The M. D. Anderson Cancer Center experience. Journal of Clinical Oncology. 26(15_suppl). 11066–11066. 1 indexed citations

Kurzrock, Razelle, Srđan Verstovšek, James R. Wright, et al.. (2005). Alternate Week Administration of the Farnesyltransferase Inhibitor Tipifarnib (ZARNESTRA®, R115777) in Patients with Myelodysplastic Syndrome: Results of a Phase 1 Study.. Blood. 106(11). 2521–2521. 4 indexed citations

Tsimberidou, Apostolia M., Frank Giles, I. Khouri, et al.. (2004). Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience. Annals of Oncology. 16(1). 139–145. 38 indexed citations

Kurzrock, Razelle, Srđan Verstovšek, James R. Wright, et al.. (2004). Phase I Study Using Alternate Week Administration of the Farnesyl Transferase Inhibitor R115777 (Zarnestra™) in Patients with Myelodysplastic Syndrome.. Blood. 104(11). 1436–1436. 7 indexed citations

Talpaz, Moshe, et al.. (2003). Sequential interleukin 3 and granulocyte‐macrophage–colony stimulating factor therapy in patients with bone marrow failure with long‐term follow‐up of responses. Cancer. 98(11). 2410–2419. 18 indexed citations

Kurzrock, Razelle, Jörge E. Cortes, Deborah A. Thomas, et al.. (2001). Pilot Study of Low-Dose Interleukin-11 in Patients With Bone Marrow Failure. Journal of Clinical Oncology. 19(21). 4165–4172. 43 indexed citations

10.

Kurzrock, Razelle, Carlos E. Bueso‐Ramos, Hagop M. Kantarjian, et al.. (2001). BCR Rearrangement–Negative Chronic Myelogenous Leukemia Revisited. Journal of Clinical Oncology. 19(11). 2915–2926. 63 indexed citations

11.

Kurzrock, Razelle, et al.. (2000). Low dose interleukin-11 is well-tolerated and induces platelet responses in myelodysplasia and other bone marrow failure states. Blood. 96. 1 indexed citations

12.

Kurzrock, Razelle, Susan R. Pilat, & Madeleine Duvic. (1999). Pentostatin Therapy of T-Cell Lymphomas With Cutaneous Manifestations. Journal of Clinical Oncology. 17(10). 3117–3121. 75 indexed citations

13.

Pazdur, Richard, James L. Abbruzzese, Robert J. Belt, et al.. (1992). Phase II evaluation of fluorouracil and recombinant α-2a-interferon in previously untreated patients with pancreatic adenocarcinoma. Cancer. 70(8). 2073–2076. 41 indexed citations

14.

Pazdur, Richard, Jaffer A. Ajani, Rodger J. Winn, et al.. (1992). A Phase II trial of 5-fluorouracil and recombinant alpha-2a-interferon in previously untreated metastatic gastric carcinoma. Cancer. 69(4). 878–882. 17 indexed citations

15.

Logothetis, Christopher J., Francisco H. Dexeus, Clayton Chong, et al.. (1989). Cisplatin, Cyclophosphamide and Doxorubicin Chemotherapy for Unresectable Urothelial Tumors: The M. D. Anderson Experience. The Journal of Urology. 141(1). 33–37. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact